Clinical Trial Update: Using Nevirapine to Prevent Mother-to-Child HIV Transmission During Breastfeeding [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating nevirapine to prevent mother-to-child HIV transmission during breastfeeding has been completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• NEVIRAPINE (nevirapine)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 3 | Status: COMPLETED | Results posted: 2013-09-16